Conversion of patients from simvastatin to lovastatin in an outpatient pharmacy clinic

American Journal of Health-System Pharmacy

Volumn 57, Issue 18, 2000, Pages 1703-1708

  Fugit, R V ^a   Resch, N D ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG COST; DRUG FORMULARY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; NOTE; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034666406     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/57.18.1703     Document Type: Note

References (16)

1. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES Study)
2. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia
3. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia
4. Summary of the UCX2 Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
5. Standards of medical care for patients with diabetes mellitus
6. Inadequate treatment with HMG-CoA reductase inhibitors by healthcare providers
7. Are 'statins' (HMG-CoA reductase inhibitors) used effectively and monitored appropriately?
8. The Lipid Treatment Assessment Project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
9. Comprehensive risk reduction in coronary patients: Attainment of goals in the AHA guidelines in U.S. patients
10. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization
11. Pharmacist management of a hyperlipidemia clinic
12. Lipid lowering in a multidisciplinary clinic compared with primary physician management
13. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system: Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care
14. Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans
15. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
16. Rationale, design, and baseline results of the Pravastatin-to-Simvastatin Conversion Lipid Optimization Program (PSCOP)